Former Executive Vice President and Chief Scientific Officer · Editas Medicine, Inc. (EDIT)

Charles Albright

A named executive officer of Editas Medicine in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$2,049,581

Salary $466,385Stock awards $325,184

FY2019: $1,996,323

4th of 6 named executive officers at Editas Medicine by FY2020 total.

6 named officers on file for Editas Medicine, FY2020

Charles Albright’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • EDIT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Editas Medicine’s whole pay program stands against its peers

  • Editas Medicine’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EDIT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2021 (DEF 14A).

Free

Get Charles Albright’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Charles Albright compensation by year

Editas Medicine Summary Compensation Table · all 5 fiscal years held
In US dollars, as Editas Medicine reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$136,538$379,275$390,654$427,774$466,385
Bonus$0$0$0$0$0
Stock awards$0$0$0$562,078$325,184
Option awards$2,506,028$765,513$1,855,626$701,454$1,249,956
Non-equity incentive$44,297$113,498$132,823$296,954$0
Pension and deferred compensation$0$0$0$0$0
All other$537$8,349$8,796$8,063$8,056
Total$2,687,400$1,266,635$2,387,899$1,996,323$2,049,581

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 20, 2021, accession 0001104659-21-052527, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Editas Medicine, Inc. filed document, accession 0001104659-21-052527. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2021.

$2.7M
$1.3M
$2.4M
$2.0M
$2.0M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU11,593$812,785—
RSU4,570$320,403—
Option26,406—$21.10
Option2,813—$24.60
Option20,854—$36.67
Option55,065—$28.05

Per the Outstanding Equity Awards at Fiscal Year-End table in Editas Medicine, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Editas Medicine’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Michelle RobertsonChief Financial Officer$3,634,342
Lisa MichaelsExecutive Vice President and Chief Medical Officer$3,166,755
Cynthia CollinsFormer President and Chief Executive Officer$3,115,950
Charles Albright · this pageFormer Executive Vice President and Chief Scientific Officer$2,049,581
Judith AbramsFormer Chief Medical Officer$304,017
Eric EkFormer interim Chief Financial Officer$104,857

The full Editas Medicine compensation record

free company brief

This page is one person within Editas Medicine's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Editas Medicine proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Editas Medicine's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Charles Albright's compensation dossier · One-time report. No refunds.